Dianthus Therapeutics Statistics
NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
84.88-0.52 (-0.61%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Dianthus Therapeutics by the numbers
Dianthus Therapeutics has a market capitalization of $4.75 billion based on 55.93M shares outstanding. With trailing EPS of $-4.24, Dianthus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.4% below its 50-day average and 4.0% above its 200-day average.
Average daily trading volume is 825.33K shares, or about $70.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DNTH valuation vs. peer median
| Metric | DNTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.75B | $5.07B | -6% |
| Avg. volume | 825.33K | 1.25M | -34% |
Peer median across 8 companies: MANE, ERAS, TVTX, GRFS, COGT, MIRM, EWTX, PTCT.
Valuation
- Market cap
- $4.75B
- Price / sales (latest FY)
- 2,331.88
- EPS (TTM)
- $-4.24
- Shares outstanding
- 55.93M
Price and trading
- Previous close
- 85.40
- Open
- 84.60
- Day range
- 84.13 – 86.61
- 52-week range
- 32.22 – 117.88
- 52-week change
- +144.61%
- 50-day moving average
- 104.00
- Beta
- —
- Volume
- 562.47K
- Average volume
- 825.33K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 4.75B
- Forward Pe
- -18.41
- Eps
- -4.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 117.88
- Week52 Low
- 32.22
- Avg Volume
- 825.33K
- Shares Outstanding
- 55.93M
- Ma50
- 104.00
- Ma200
- 81.60
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -27.99%
- Pct From52w Low
- 163.44%